182 related articles for article (PubMed ID: 34114784)
1. Impact of the preoperative modified Glasgow Prognostic Score on disease outcome after radical cystectomy for urothelial carcinoma of the bladder.
Schuettfort VM; Gust K; D'Andrea D; Quhal F; Mostafaei H; Laukhtina E; Mori K; Rink M; Abufaraj M; Karakiewicz PI; Luzzago S; Rouprêt M; Enikeev D; Zimmermann K; Deuker M; Moschini M; Sari Motlagh R; Grossmann NC; Katayama S; Pradere B; Shariat SF
Minerva Urol Nephrol; 2022 Jun; 74(3):302-312. PubMed ID: 34114784
[TBL] [Abstract][Full Text] [Related]
2. Impact of preoperative systemic immune-inflammation Index on oncologic outcomes in bladder cancer patients treated with radical cystectomy.
Grossmann NC; Schuettfort VM; Pradere B; Rajwa P; Quhal F; Mostafaei H; Laukhtina E; Mori K; Motlagh RS; Aydh A; Katayama S; Moschini M; Fankhauser CD; Hermanns T; Abufaraj M; Mun DH; Zimmermann K; Fajkovic H; Haydter M; Shariat SF
Urol Oncol; 2022 Mar; 40(3):106.e11-106.e19. PubMed ID: 34810077
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Role of Preoperative Vascular Cell Adhesion Molecule-1 Plasma Levels in Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy.
Mori K; Schuettfort VM; Katayama S; Laukhtina E; Pradere B; Quhal F; Sari Motlagh R; Mostafaei H; Grossmann NC; Rajwa P; Teoh JY; Resch I; Fajkovic H; Moschini M; D'andrea D; Abufaraj M; Karakiewicz PI; Lotan Y; Scherr D; Egawa S; Compérat E; Shariat SF;
Ann Surg Oncol; 2022 Aug; 29(8):5307-5316. PubMed ID: 35347517
[TBL] [Abstract][Full Text] [Related]
4. Impact of preoperative serum albumin-globulin ratio on disease outcome after radical cystectomy for urothelial carcinoma of the bladder.
Schuettfort VM; D Andrea D; Quhal F; Mostafaei H; Laukhtina E; Mori K; Sari Motlagh R; Rink M; Abufaraj M; Karakiewicz PI; Luzzago S; Rouprêt M; Chlosta P; Babjuk M; Deuker M; Moschini M; Shariat SF; Pradere B
Urol Oncol; 2021 Apr; 39(4):235.e5-235.e14. PubMed ID: 33189530
[TBL] [Abstract][Full Text] [Related]
5. A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinoma.
Schuettfort VM; D'Andrea D; Quhal F; Mostafaei H; Laukhtina E; Mori K; König F; Rink M; Abufaraj M; Karakiewicz PI; Luzzago S; Rouprêt M; Enikeev D; Zimmermann K; Deuker M; Moschini M; Sari Motlagh R; Grossmann NC; Katayama S; Pradere B; Shariat SF
BJU Int; 2022 Feb; 129(2):182-193. PubMed ID: 33650265
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of modified Glasgow Prognostic Score in non-muscle-invasive bladder cancer.
Kimura S; D' Andrea D; Soria F; Foerster B; Abufaraj M; Vartolomei MD; Iwata T; Karakiewicz PI; Rink M; Gust KM; Egawa S; Shariat SF
Urol Oncol; 2019 Mar; 37(3):179.e19-179.e28. PubMed ID: 30580906
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Impact of Preoperative Plasma Levels of Urokinase Plasminogen Activator Proteins on Disease Outcomes after Radical Cystectomy.
Schuettfort VM; Pradere B; D'Andrea D; Grossmann NC; Quhal F; Mostafaei H; Laukhtina E; Mori K; Rink M; Karakiewicz PI; Motlagh RS; Katayama S; Lotan Y; Scherr D; Abufaraj M; Fajkovica H; Compérat E; Enikeev D; Shariat SF
J Urol; 2021 Nov; 206(5):1122-1131. PubMed ID: 34181469
[TBL] [Abstract][Full Text] [Related]
8. The Value of Preoperative Plasma VEGF Levels in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy.
Mori K; Schuettfort VM; Katayama S; Laukhtina E; Pradere B; Quhal F; Sari Motlagh R; Mostafaei H; Grossmann NC; Rajwa P; König F; Aydh A; Soria F; Moschini M; Karakiewicz PI; Lotan Y; Scherr D; Haydter M; Nyirady P; Teoh JYC; Egawa S; Compérat E; Shariat SF
Eur Urol Focus; 2022 Jul; 8(4):972-979. PubMed ID: 34454852
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis.
Vetterlein MW; Seisen T; May M; Nuhn P; Gierth M; Mayr R; Fritsche HM; Burger M; Novotny V; Froehner M; Wirth MP; Protzel C; Hakenberg OW; Roghmann F; Palisaar RJ; Noldus J; Pycha A; Bastian PJ; Trinh QD; Xylinas E; Shariat SF; Rink M; Chun FK; Dahlem R; Fisch M; Aziz A;
Eur Urol Focus; 2018 Mar; 4(2):252-259. PubMed ID: 28753775
[TBL] [Abstract][Full Text] [Related]
10. Impact of preoperative plasma levels of interleukin 6 and interleukin 6 soluble receptor on disease outcomes after radical cystectomy for bladder cancer.
Schuettfort VM; Pradere B; Trinh QD; D'Andrea D; Quhal F; Mostafaei H; Laukhtina E; Mori K; Sari Motlagh R; Rink M; Karakiewicz PI; Chlosta P; Yuen-Chun Teoh J; Lotan Y; Scherr D; Abufaraj M; Moschini M; Shariat SF
Cancer Immunol Immunother; 2022 Jan; 71(1):85-95. PubMed ID: 34023914
[TBL] [Abstract][Full Text] [Related]
11. Preoperative plasma level of endoglin as a predictor for disease outcomes after radical cystectomy for nonmetastatic urothelial carcinoma of the bladder.
Laukhtina E; Schuettfort VM; D'Andrea D; Pradere B; Mori K; Quhal F; Sari Motlagh R; Mostafaei H; Katayama S; Grossmann NС; Rajwa P; Zeinler F; Abufaraj M; Moschini M; Zimmermann K; Karakiewicz PI; Fajkovic H; Scherr D; Compérat E; Nyirady P; Rink M; Enikeev D; Shariat SF
Mol Carcinog; 2022 Jan; 61(1):5-18. PubMed ID: 34587660
[TBL] [Abstract][Full Text] [Related]
12. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making.
Aziz A; Shariat SF; Roghmann F; Brookman-May S; Stief CG; Rink M; Chun FK; Fisch M; Novotny V; Froehner M; Wirth MP; Schnabel MJ; Fritsche HM; Burger M; Pycha A; Brisuda A; Babjuk M; Vallo S; Haferkamp A; Roigas J; Noldus J; Stredele R; Volkmer B; Bastian PJ; Xylinas E; May M
BJU Int; 2016 Feb; 117(2):272-9. PubMed ID: 25381844
[TBL] [Abstract][Full Text] [Related]
13. Predictive and Prognostic Role of the Neutrophil-to-Lymphocyte Ratio in Muscle Invasive Bladder Cancer Treated With Neoadjuvant Chemotherapy and Radical Cystectomy.
von Deimling M; Schuettfort VM; D'Andrea D; Pradere B; Grossmann NC; Kawada T; Yanagisawa T; Majdoub M; Laukhtina E; Rajwa P; Quhal F; Mostafaei H; Fajkovic H; Teoh JY; Moschini M; Karakiewicz PI; Fisch M; Rink M; Shariat SF
Clin Genitourin Cancer; 2023 Aug; 21(4):430-441. PubMed ID: 36781346
[TBL] [Abstract][Full Text] [Related]
14. Clinical Lymphadenopathy in Urothelial Cancer: A Transatlantic Collaboration on Performance of Cross-sectional Imaging and Oncologic Outcomes in Patients Treated with Radical Cystectomy Without Neoadjuvant Chemotherapy.
Moschini M; Morlacco A; Briganti A; Hu B; Colombo R; Montorsi F; Frank I; Daneshmand S; Karnes RJ
Eur Urol Focus; 2018 Mar; 4(2):245-251. PubMed ID: 28753820
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of the systemic inflammation modified Glasgow prognostic score in patients with upper tract urothelial carcinoma (UTUC) treated with radical nephroureterectomy: Results from a large multicenter international collaboration.
Soria F; Giordano A; D'Andrea D; Moschini M; Rouprêt M; Margulis V; Karakiewicz PI; Briganti A; Bensalah K; Mathieu R; Chlosta P; Babjuk M; Glybochko PV; Enikeev DV; Remzi M; Gust K; Gontero P; Shariat SF
Urol Oncol; 2020 Jun; 38(6):602.e11-602.e19. PubMed ID: 32037197
[TBL] [Abstract][Full Text] [Related]
16. Oncological impact of inflammatory biomarkers in elderly patients treated with radical cystectomy for urothelial bladder cancer.
Mari A; Muto G; Di Maida F; Tellini R; Bossa R; Bisegna C; Campi R; Cocci A; Viola L; Grosso A; Scelzi S; Lapini A; Carini M; Minervini A
Arab J Urol; 2020 Aug; 19(1):2-8. PubMed ID: 33763243
[TBL] [Abstract][Full Text] [Related]
17. Impact of Preoperative Plasma Potassium Levels on Oncological Outcomes, Major Complications, and 30-Day Mortality in Bladder Cancer Patients Undergoing Radical Cystectomy.
Klemm J; Shariat SF; Laukhtina E; Rajwa P; Vetterlein MW; Schuettfort VM; von Deimling M; Dahlem R; Fisch M; Rink M
Clin Genitourin Cancer; 2024 Jun; 22(3):102079. PubMed ID: 38614853
[TBL] [Abstract][Full Text] [Related]
18. Development of a Preoperative Nomogram Incorporating Biomarkers of Systemic Inflammatory Response to Predict Nonorgan-confined Urothelial Carcinoma of the Bladder at Radical Cystectomy.
Lucca I; Hofbauer SL; Leitner CV; de Martino M; Özsoy M; Susani M; Shariat SF; Klatte T
Urology; 2016 Sep; 95():132-8. PubMed ID: 27316373
[TBL] [Abstract][Full Text] [Related]
19. Lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio as biomarkers for predicting lymph node metastasis and survival in patients treated with radical cystectomy.
D'Andrea D; Moschini M; Gust KM; Abufaraj M; Özsoy M; Mathieu R; Soria F; Briganti A; Rouprêt M; Karakiewicz PI; Shariat SF
J Surg Oncol; 2017 Mar; 115(4):455-461. PubMed ID: 28105663
[TBL] [Abstract][Full Text] [Related]
20. Urothelial carcinoma of the bladder with isolated lymph node metastasis: Natural history and outcomes following surgical resection.
Morton E; Kaul S; Fleishman A; Korets R; Chang P; Wagner A; Kim SP; Bellmunt J; Kaplan I; Olumi AF; Gershman B
Urol Oncol; 2023 May; 41(5):255.e7-255.e14. PubMed ID: 36470805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
